---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-120977"
form_type: "8-K"
ticker: "ATXI"
cik: "0001644963"
company_name: "AVENUE THERAPEUTICS, INC."
filed_at: "2023-11-24T23:59:59+00:00"
generated_at: "2026-06-07T21:52:52.953479+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Avenue Therapeutics receives Nasdaq delisting notice for continued non-compliance with equity rule

## Summary
- Failed to meet Nasdaq's $2.5M stockholders' equity requirement by Nov 15, 2023 extension deadline.
- Staff notified of delisting determination on Nov 20, 2023; company to request hearing to stay delisting.
- No immediate effect on trading; stock continues on Nasdaq under ATXI pending hearing outcome.
- Company cannot assure that panel will grant continued listing or that compliance can be shown within any extension.

## SEC filing metadata
- accession: 0001104659-23-120977
- form_type: 8-K
- ticker: ATXI
- cik: 0001644963
- company_name: AVENUE THERAPEUTICS, INC.
- filed_at: 2023-11-24T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1644963/000110465923120977/0001104659-23-120977-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1644963/000110465923120977/tm2331507d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-120977
- JSON: https://secwatch.observer/filing/0001104659-23-120977.json
- Plain text: https://secwatch.observer/filing/0001104659-23-120977.txt

## Key facts
- Listing & Compliance Notices
  AVENUE THERAPEUTICS, INC. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: stockholders equity
  - Rules: 5550(b)(1)
  source text: November 20, 2023, the Staff formally notified the Company that it had determined to delist the Company’s securities from Nasdaq based upon the Company’s continued non-compliance with the Rule unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “ Panel ”). The Company intends to timely request a hearing before the Panel, which request will stay any further action by Nasdaq at least pending completion of the hearing and the expiration of any extension that may be granted by the Panel to the Company. The Company is considering all options available to it to regain
  evidence_url: https://www.sec.gov/Archives/edgar/data/1644963/000110465923120977/0001104659-23-120977-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.